Voyager Therapeutics Ownership 2024 | Who Owns Voyager Therapeutics Now?
Institutional Ownership
64.91%
Insider Ownership
16.86%
Retail Ownership
18.23%
Institutional Holders
129.00
Voyager Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 9.30% | 0.00% | 5,312,617 | 915,173 | 20.81% | 42,022,801 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 9.10% | 0.52% | 5,200,000 | 528,000 | 11.30% | 41,132,000 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 6.86% | 0.95% | 3,917,546 | - | - | 30,987,789 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.32% | 0.00% | 3,038,564 | -193,134 | -5.98% | 24,035,041 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 4.01% | 0.09% | 2,292,000 | - | - | 18,129,720 | Jun 30, 2024 |
| STATE STREET CORP | 3.13% | 0.00% | 1,789,189 | 40,021 | 2.29% | 14,152,485,000 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 2.80% | 2.43% | 1,601,527 | 1,601,527 | 100.00% | 12,668,079 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.88% | 0.00% | 1,072,769 | 100,405 | 10.33% | 8,487,159 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 1.78% | 0.00% | 1,019,332 | 249,659 | 32.44% | 8,062,916 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.73% | 0.00% | 989,549 | -52,381 | -5.03% | 7,828,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.42% | 0.00% | 813,680 | -291,875 | -26.40% | 6,435,997 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.14% | 0.00% | 648,760 | 294,317 | 83.04% | 5,131,692 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.05% | 0.35% | 600,000 | - | - | 4,746,000 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.97% | 0.01% | 554,214 | 2,638 | 0.48% | 4,383,833,000 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.88% | 0.01% | 502,375 | -291,259 | -36.70% | 3,973,787 | Jun 30, 2024 |
| MORGAN STANLEY | 0.87% | 0.00% | 496,969 | 214,809 | 76.13% | 3,931,024 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.78% | 0.00% | 443,984 | 62,275 | 16.31% | 3,511,913 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.66% | 0.00% | 374,161 | -15,655 | -4.02% | 2,959,613,000 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.53% | 0.02% | 300,000 | - | - | 2,373,000 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.52% | 0.00% | 294,420 | 44,289 | 17.71% | 2,328,865 | Jun 30, 2024 |
Voyager Therapeutics's largest institutional shareholder is BLACKROCK INC., holding 9.30% of the company's total share outstanding, currently valued at $42.02M. The top 10 institutional shareholders own together 45.93% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2.80% | 2.43% | 1,601,527 | 1,601,527 | 100.00% | 12,668,079 | Jun 30, 2024 |
| ECOR1 CAPITAL, LLC | 6.86% | 0.95% | 3,917,546 | - | - | 30,987,789 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 9.10% | 0.52% | 5,200,000 | 528,000 | 11.30% | 41,132,000 | Jun 30, 2024 |
| SUMMERHAVEN INVESTMENT MANAGEMENT, LLC | 0.14% | 0.40% | 77,293 | 1,921 | 2.55% | 611,388 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 1.05% | 0.35% | 600,000 | - | - | 4,746,000 | Jun 30, 2024 |
| GLOBEFLEX CAPITAL L P | 0.51% | 0.24% | 291,293 | -18,215 | -5.89% | 2,304,128 | Jun 30, 2024 |
| ADVANTAGE ALPHA CAPITAL PARTNERS LP | 0.19% | 0.19% | 110,681 | -11,630 | -9.51% | 875,487 | Jun 30, 2024 |
| PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC | 0.22% | 0.15% | 127,894 | 127,894 | 100.00% | 1,011,642 | Jun 30, 2024 |
| SEMANTEON CAPITAL MANAGEMENT, LP | 0.04% | 0.13% | 22,715 | 22,715 | 100.00% | 179,676 | Jun 30, 2024 |
| HUSSMAN STRATEGIC ADVISORS, INC. | 0.09% | 0.11% | 52,500 | - | - | 415,275 | Jun 30, 2024 |
| HUNTER PERKINS CAPITAL MANAGEMENT, LLC | 0.11% | 0.10% | 62,015 | -3,150 | -4.83% | 491,000 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 4.01% | 0.09% | 2,292,000 | - | - | 18,129,720 | Jun 30, 2024 |
| VIRTUS INVESTMENT ADVISERS, INC. | 0.02% | 0.08% | 12,648 | - | - | 100,046 | Jun 30, 2024 |
| CLARIVEST ASSET MANAGEMENT LLC | 0.18% | 0.08% | 102,822 | 2,699 | 2.70% | 813,322 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.10% | 0.08% | 55,857 | -125,000 | -69.12% | 441,829 | Jun 30, 2024 |
| VIRTUS FUND ADVISERS, LLC | 0.00% | 0.08% | 2,439 | 79 | 3.35% | 19,292 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.13% | 0.06% | 75,705 | 75,705 | 100.00% | 598,827 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.32% | 0.03% | 182,831 | 3,060 | 1.70% | 1,446,193 | Jun 30, 2024 |
| FIDUCIARY TRUST CO | 0.45% | 0.03% | 259,397 | - | - | 2,051,830 | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.04% | 0.03% | 22,976 | -241 | -1.04% | 181,740 | Jun 30, 2024 |
The largest Voyager Therapeutics shareholder by % of total assets is GREAT POINT PARTNERS LLC. The company owns 1.60M shares of Voyager Therapeutics (VYGR), representing 2.43% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2.80% | 2.43% | 1,601,527 | 1,601,527 | 100.00% | 12,668,079 | Jun 30, 2024 |
| BLACKROCK INC. | 9.30% | 0.00% | 5,312,617 | 915,173 | 20.81% | 42,022,801 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 9.10% | 0.52% | 5,200,000 | 528,000 | 11.30% | 41,132,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.14% | 0.00% | 648,760 | 294,317 | 83.04% | 5,131,692 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 1.78% | 0.00% | 1,019,332 | 249,659 | 32.44% | 8,062,916 | Jun 30, 2024 |
| MORGAN STANLEY | 0.87% | 0.00% | 496,969 | 214,809 | 76.13% | 3,931,024 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | 0.28% | 0.01% | 162,400 | 162,400 | 100.00% | 1,284,584 | Jun 30, 2024 |
| PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC | 0.22% | 0.15% | 127,894 | 127,894 | 100.00% | 1,011,642 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.20% | 0.00% | 115,300 | 115,300 | 100.00% | 912,023 | Jun 30, 2024 |
| INVESCO LTD. | 0.23% | 0.00% | 131,963 | 110,907 | 526.72% | 1,043,828 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.88% | 0.00% | 1,072,769 | 100,405 | 10.33% | 8,487,159 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.13% | 0.06% | 75,705 | 75,705 | 100.00% | 598,827 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.78% | 0.00% | 443,984 | 62,275 | 16.31% | 3,511,913 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.52% | 0.00% | 294,420 | 44,289 | 17.71% | 2,328,865 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.43% | 0.00% | 246,992 | 42,963 | 21.06% | 1,953,707 | Jun 30, 2024 |
| STATE STREET CORP | 3.13% | 0.00% | 1,789,189 | 40,021 | 2.29% | 14,152,485,000 | Jun 30, 2024 |
| STRS OHIO | 0.11% | 0.00% | 61,100 | 28,000 | 84.59% | 483,301,000 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.13% | 0.00% | 72,461 | 26,014 | 56.01% | 573,153 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 24,749 | 24,749 | 100.00% | 195,765 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 22,884 | 22,884 | 100.00% | 180,845 | Jun 30, 2024 |
As of Jun 30 2024, Voyager Therapeutics's largest institutional buyer is GREAT POINT PARTNERS LLC. The company purchased 1.60M stocks of VYGR, valued at $12.67M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ACADIAN ASSET MANAGEMENT LLC | 0.19% | 0.00% | 106,825 | -353,025 | -76.77% | 843,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.42% | 0.00% | 813,680 | -291,875 | -26.40% | 6,435,997 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.88% | 0.01% | 502,375 | -291,259 | -36.70% | 3,973,787 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.32% | 0.00% | 3,038,564 | -193,134 | -5.98% | 24,035,041 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.10% | 0.08% | 55,857 | -125,000 | -69.12% | 441,829 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -100,725 | -100.00% | - | Jun 30, 2024 |
| AXA S.A. | - | - | - | -99,000 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -94,448 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.03% | 0.03% | 18,634 | -72,900 | -79.64% | 147,395 | Jun 30, 2024 |
| AVIVA PLC | - | - | - | -70,285 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.11% | 0.00% | 63,200 | -64,900 | -50.66% | 499,912 | Jun 30, 2024 |
| MAN GROUP PLC | 0.03% | 0.00% | 14,957 | -58,272 | -79.58% | 118,310 | Jun 30, 2024 |
| ALPHA DNA INVESTMENT MANAGEMENT LLC | - | - | - | -57,588 | -100.00% | - | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.73% | 0.00% | 989,549 | -52,381 | -5.03% | 7,828,000 | Jun 30, 2024 |
| BLACKSTONE INC. | - | - | - | -50,848 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -47,808 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.10% | 0.00% | 58,492 | -45,792 | -43.91% | 462,672 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.48% | 0.00% | 275,443 | -41,212 | -13.01% | 2,178,755 | Jun 30, 2024 |
| WINTON GROUP LTD | 0.06% | 0.02% | 36,027 | -38,484 | -51.65% | 284,974 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -32,005 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Voyager Therapeutics's biggest institutional seller is ACADIAN ASSET MANAGEMENT LLC. The company sold -0.35M shares of VYGR, valued at $843.00K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2.80% | 2.43% | 1,601,527 | 1,601,527 | 100.00% | 12,668,079 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | 0.28% | 0.01% | 162,400 | 162,400 | 100.00% | 1,284,584 | Jun 30, 2024 |
| PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC | 0.22% | 0.15% | 127,894 | 127,894 | 100.00% | 1,011,642 | Jun 30, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.20% | 0.00% | 115,300 | 115,300 | 100.00% | 912,023 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.13% | 0.06% | 75,705 | 75,705 | 100.00% | 598,827 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 24,749 | 24,749 | 100.00% | 195,765 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 22,884 | 22,884 | 100.00% | 180,845 | Jun 30, 2024 |
| SEMANTEON CAPITAL MANAGEMENT, LP | 0.04% | 0.13% | 22,715 | 22,715 | 100.00% | 179,676 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.03% | 0.00% | 18,707 | 18,707 | 100.00% | 147,972 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.03% | 0.02% | 15,078 | 15,078 | 100.00% | 119,267 | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | 0.02% | 0.02% | 12,159 | 12,159 | 100.00% | 96,178 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.02% | 0.00% | 10,780 | 10,780 | 100.00% | 85,000 | Jun 30, 2024 |
| INCEPTIONR LLC | 0.02% | 0.02% | 10,053 | 10,053 | 100.00% | 79,519 | Jun 30, 2024 |
| ARCADIA INVESTMENT MANAGEMENT CORP/MI | 0.00% | 0.00% | 2,000 | 2,000 | 100.00% | 15,820 | Jun 30, 2024 |
| PICTON MAHONEY ASSET MANAGEMENT | 0.00% | 0.00% | 798 | 798 | 100.00% | 6,000 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 411 | 411 | 100.00% | 3,252 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 155 | 155 | 100.00% | 1,226 | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.00% | 100 | 100 | 100.00% | 791 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 30 | 30 | 100.00% | 237 | Jun 30, 2024 |
| PLANNING CAPITAL MANAGEMENT CORP | - | 0.00% | 15 | 15 | 100.00% | 119 | Jun 30, 2024 |
Voyager Therapeutics's largest new institutional shareholder by number of shares is GREAT POINT PARTNERS LLC, purchased 1.60M shares, valued at $12.67M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | - | - | - | -100,725 | -100.00% | - | Jun 30, 2024 |
| AXA S.A. | - | - | - | -99,000 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -94,448 | -100.00% | - | Jun 30, 2024 |
| AVIVA PLC | - | - | - | -70,285 | -100.00% | - | Jun 30, 2024 |
| ALPHA DNA INVESTMENT MANAGEMENT LLC | - | - | - | -57,588 | -100.00% | - | Jun 30, 2024 |
| BLACKSTONE INC. | - | - | - | -50,848 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -47,808 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -32,005 | -100.00% | - | Jun 30, 2024 |
| STATE OF WYOMING | - | - | - | -30,948 | -100.00% | - | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | - | - | - | -28,896 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -24,673 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -24,029 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -22,112 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -21,341 | -100.00% | - | Jun 30, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | - | - | - | -20,320 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -19,397 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -16,168 | -100.00% | - | Jun 30, 2024 |
| BAILARD, INC. | - | - | - | -13,700 | -100.00% | - | Jun 30, 2024 |
| PROSHARE ADVISORS LLC | - | - | - | -10,876 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -10,039 | -100.00% | - | Jun 30, 2024 |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | - | - | - | -7,593 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -7,413 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,743 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -1,500 | -100.00% | - | Jun 30, 2024 |
| MACROVIEW INVESTMENT MANAGEMENT LLC | - | - | - | -858 | -100.00% | - | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -43 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -6 | -100.00% | - | Jun 30, 2024 |
Voyager Therapeutics's largest sold out institutional shareholder by shares sold is MILLENNIUM MANAGEMENT LLC, sold -0.10M shares, valued at -, as of undefined.
Voyager Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Tema ETF Trust | 0.34% | 14,960 | 14,960 | - | Feb 29, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.22% | 738,846 | 51,794 | 7.54% | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.22% | 534,308 | - | - | Jan 31, 2024 |
| BNY MELLON VARIABLE INVESTMENT FUND | 0.15% | 36,522 | - | - | Mar 31, 2024 |
| RMB INVESTORS TRUST | 0.14% | 75,000 | - | - | Dec 31, 2023 |
| BlackRock Health Sciences Trust II | 0.13% | 349,705 | 184,840 | 112.12% | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.13% | 32,205 | 32,205 | - | Mar 31, 2024 |
| TOCQUEVILLE TRUST | 0.11% | 15,000 | - | - | Jan 31, 2024 |
| NEEDHAM FUNDS INC | 0.07% | 141,924 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.06% | 138,000 | - | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 28,600 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.05% | 8,697 | -2,234 | -20.44% | Mar 28, 2024 |
| Gabelli Healthcare & WellnessRx Trust | 0.04% | 5,000 | - | - | Dec 29, 2023 |
| IndexIQ ETF Trust | 0.04% | 89,662 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC. | 0.04% | 87,061 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.04% | 457,063 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY GROWTH FUNDS, INC. | 0.03% | 5,068 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.03% | 42,811 | 7,830 | 22.38% | Mar 31, 2024 |
| ETFis Series Trust I | 0.03% | 36,525 | - | - | Jan 31, 2024 |
| LEGG MASON PARTNERS VARIABLE EQUITY TRUST | 0.02% | 93,273 | - | - | Dec 29, 2023 |
| LEGG MASON PARTNERS INVESTMENT TRUST | 0.02% | 1,034,737 | - | - | Mar 28, 2024 |
| FORUM FUNDS II | 0.02% | 17,911 | 6,763 | 60.67% | Mar 31, 2024 |
| HUSSMAN INVESTMENT TRUST | 0.01% | 52,500 | - | - | Dec 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.01% | 138,129 | 52,290 | 60.92% | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 60,352 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,793 | 880 | 17.91% | Mar 31, 2024 |
| GABELLI EQUITY TRUST INC | 0.01% | 11,481 | - | - | Dec 29, 2023 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 18,186 | - | - | Mar 31, 2024 |
| UBS FUNDS | 0.01% | 35,398 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 45,215 | - | - | Aug 31, 2023 |
| Principal Exchange-Traded Funds | 0.01% | 74,000 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.01% | 695,183 | 273,030 | 64.68% | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,396,322 | 185,798 | 8.41% | Mar 31, 2024 |
| Lattice Strategies Trust | 0.01% | 8,400 | -10,973 | -56.64% | Mar 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.00% | 5,700 | - | - | Mar 28, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 14,649 | - | - | Feb 29, 2024 |
| SSGA FUNDS | 0.00% | 2,005 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 842 | - | - | Mar 31, 2024 |
| Legg Mason ETF Investment Trust | 0.00% | 7,458 | 2,758 | 58.68% | Mar 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 117,784 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 79,308 | - | - | Mar 31, 2024 |
| AMG Funds I | 0.00% | 6,507 | - | - | Jan 31, 2024 |
| JNL VARIABLE FUND LLC | 0.00% | 17,568 | - | - | Mar 31, 2020 |
| ALPS ETF Trust | 0.00% | 34,213 | -3,989 | -10.44% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 30,761 | 205 | 0.67% | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 10,014 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 84,737 | -3,436 | -3.90% | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 36,890 | -425 | -1.14% | Mar 31, 2024 |
| AMG FUNDS III | 0.00% | 9,799 | - | - | Mar 28, 2024 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 28,153 | 4,767 | 20.38% | Mar 31, 2024 |
| GPS Funds I | 0.00% | 8,965 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,923 | 1,300 | 49.56% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 299,362 | 19,304 | 6.89% | Feb 29, 2024 |
| BMO FUNDS, INC. | 0.00% | 54,976 | -737 | -1.32% | Aug 31, 2020 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 32,198 | 4,259 | 15.24% | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 31,731 | 5,883 | 22.76% | Mar 31, 2024 |
| BNY MELLON FUNDS TRUST | 0.00% | 61,516 | - | - | Aug 31, 2023 |
| BlackRock ETF Trust | 0.00% | 718 | 407 | 130.87% | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 47,929 | - | - | Feb 29, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 61,723 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 172,757 | 168,946 | 4433.11% | Jan 31, 2024 |
| AdvisorShares Trust | 0.00% | 2,800 | - | - | Mar 28, 2024 |
| Dimensional ETF Trust | 0.00% | 281,690 | 20,844 | 7.99% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 602,659 | 126,182 | 26.48% | Jan 31, 2024 |
| ProFunds | 0.00% | 6,358 | 6,091 | 2281.27% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 11,418 | 755 | 7.08% | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 10,937 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 213 | - | - | Apr 30, 2021 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,987 | 221 | 12.51% | Mar 31, 2024 |
| Virtus Strategy Trust | 0.00% | 7,788 | - | - | Mar 28, 2024 |
| Virtus Investment Trust | 0.00% | 12,648 | 11,515 | 1016.33% | Mar 28, 2024 |
| Global X Funds | 0.00% | 15,812 | - | - | Jan 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 17,869 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 10,154 | -3,114 | -23.47% | Mar 31, 2024 |
| Northern Lights Fund Trust IV | 0.00% | 103,039 | 13,495 | 15.07% | Feb 29, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 26,129 | -1,016 | -3.74% | Feb 29, 2024 |
| North Square Investments Trust | 0.00% | 2,526 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 17,104 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 16,500 | 6,700 | 68.37% | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 200 | - | - | Dec 31, 2023 |
| Guggenheim Variable Funds Trust | 0.00% | 908 | - | - | Dec 31, 2023 |
| NORTHERN FUNDS | 0.00% | 28,957 | 3,498 | 13.74% | Mar 28, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 107,536 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 496 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 15,933 | 13,668 | 603.44% | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 4,188 | - | - | Jan 31, 2024 |
| RBC FUNDS TRUST | 0.00% | 17,900 | 17,900 | - | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 19,517 | 13,669 | 233.74% | Jan 31, 2024 |
| NORTHERN LIGHTS FUND TRUST II | 0.00% | 1,263 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 1,652,492 | 201,171 | 13.86% | Mar 31, 2024 |
| Meeder Funds | 0.00% | 370 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 145,952 | 17,909 | 13.99% | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 86,688 | -5,575 | -6.04% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 290 | -3,025 | -91.25% | Dec 31, 2023 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 15,010 | - | - | Feb 29, 2024 |
| Advisors' Inner Circle Fund II | 0.00% | 56,000 | - | - | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 25,032 | - | - | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 1,439 | 289 | 25.13% | Mar 31, 2024 |
| Franklin Templeton ETF Trust | 0.00% | 10,812 | 10,812 | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 17,144 | - | - | Jan 31, 2024 |
Voyager Therapeutics's largest mutual fund holder by % of total assets is "Tema ETF Trust", owning 14.96K shares, compromising 0.34% of its total assets.
Voyager Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 129 | -4.44% |
| 31 Mar, 24 | 135 | 22.73% |
| 31 Dec, 23 | 110 | -3.51% |
| 30 Sep, 23 | 114 | 4.59% |
| 30 Jun, 23 | 109 | 25.29% |
| 31 Mar, 23 | 87 | 22.54% |
| 31 Dec, 22 | 71 | - |
| 30 Sep, 22 | 71 | -8.97% |
| 30 Jun, 22 | 78 | 2.63% |
| 31 Mar, 22 | 76 | 28.81% |
| 31 Dec, 21 | 59 | -11.94% |
| 30 Sep, 21 | 67 | -11.84% |
| 30 Jun, 21 | 76 | -21.65% |
| 31 Mar, 21 | 97 | -2.02% |
| 31 Dec, 20 | 99 | -8.33% |
| 30 Sep, 20 | 108 | -3.57% |
| 30 Jun, 20 | 112 | -4.27% |
| 31 Mar, 20 | 117 | -15.83% |
| 31 Dec, 19 | 139 | 5.30% |
| 30 Sep, 19 | 132 | 2.33% |
| 30 Jun, 19 | 129 | 15.18% |
| 31 Mar, 19 | 112 | -1.75% |
| 31 Dec, 18 | 114 | -6.56% |
| 30 Sep, 18 | 122 | -3.94% |
| 30 Jun, 18 | 127 | 14.41% |
| 31 Mar, 18 | 111 | 9.90% |
| 31 Dec, 17 | 101 | 32.89% |
| 30 Sep, 17 | 76 | 46.15% |
| 30 Jun, 17 | 52 | 13.04% |
| 31 Mar, 17 | 46 | -16.36% |
| 31 Dec, 16 | 55 | 10.00% |
| 30 Sep, 16 | 50 | 2.04% |
| 30 Jun, 16 | 49 | 13.95% |
| 31 Mar, 16 | 43 | 22.86% |
| 31 Dec, 15 | 35 | - |
| 30 Jun, 10 | 1 | - |
As of 30 Jun 24, 129 institutions are holding Voyager Therapeutics's shares, representing a decrease of -4.44% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 37,074,437 | 7.46% |
| 31 Mar, 24 | 34,500,823 | 33.24% |
| 31 Dec, 23 | 25,893,556 | -1.14% |
| 30 Sep, 23 | 26,192,943 | 1.46% |
| 30 Jun, 23 | 25,817,269 | 13.55% |
| 31 Mar, 23 | 22,736,451 | -0.43% |
| 31 Dec, 22 | 22,833,566 | -0.61% |
| 30 Sep, 22 | 22,973,885 | 0.26% |
| 30 Jun, 22 | 22,914,615 | 7.86% |
| 31 Mar, 22 | 21,245,536 | 20.80% |
| 31 Dec, 21 | 17,587,798 | -17.53% |
| 30 Sep, 21 | 21,327,489 | -6.05% |
| 30 Jun, 21 | 22,700,706 | -13.57% |
| 31 Mar, 21 | 26,265,616 | -3.80% |
| 31 Dec, 20 | 27,303,735 | -1.53% |
| 30 Sep, 20 | 27,727,636 | -5.99% |
| 30 Jun, 20 | 29,492,954 | -1.49% |
| 31 Mar, 20 | 29,940,323 | -1.94% |
| 31 Dec, 19 | 30,533,156 | 0.54% |
| 30 Sep, 19 | 30,368,136 | 4.76% |
| 30 Jun, 19 | 28,989,591 | 6.74% |
| 31 Mar, 19 | 27,159,951 | -2.26% |
| 31 Dec, 18 | 27,786,932 | -3.84% |
| 30 Sep, 18 | 28,897,987 | -0.64% |
| 30 Jun, 18 | 29,083,589 | 7.51% |
| 31 Mar, 18 | 27,053,018 | 7.47% |
| 31 Dec, 17 | 25,173,586 | 122.51% |
| 30 Sep, 17 | 11,313,482 | 3.33% |
| 30 Jun, 17 | 10,949,069 | -1.01% |
| 31 Mar, 17 | 11,060,819 | 0.98% |
| 31 Dec, 16 | 10,954,007 | 2.97% |
| 30 Sep, 16 | 10,637,832 | 0.37% |
| 30 Jun, 16 | 10,598,354 | 5.81% |
| 31 Mar, 16 | 10,016,303 | -3.72% |
| 31 Dec, 15 | 10,403,219 | - |
| 30 Jun, 10 | 1,500 | - |
Voyager Therapeutics (VYGR) has 37.07M shares outstanding as of 30 Jun 24, up 7.46% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 64.91% | 1.01% |
| 31 Mar, 24 | 80.20% | 2.30% |
| 31 Dec, 23 | 59.03% | 1.63% |
| 30 Sep, 23 | 60.19% | 1.49% |
| 30 Jun, 23 | 63.54% | 2.03% |
| 31 Mar, 23 | 55.96% | 1.59% |
| 31 Dec, 22 | 59.23% | 1.66% |
| 30 Sep, 22 | 59.66% | 1.67% |
| 30 Jun, 22 | 59.83% | 1.92% |
| 31 Mar, 22 | 55.84% | 2.56% |
| 31 Dec, 21 | 46.69% | 1.47% |
| 30 Sep, 21 | 56.45% | 1.55% |
| 30 Jun, 21 | 60.40% | 1.23% |
| 31 Mar, 21 | 70.04% | 1.30% |
| 31 Dec, 20 | 73.53% | 1.33% |
| 30 Sep, 20 | 74.45% | 1.17% |
| 30 Jun, 20 | 79.65% | 1.21% |
| 31 Mar, 20 | 81.00% | 1.12% |
| 31 Dec, 19 | 85.05% | 1.25% |
| 30 Sep, 19 | 82.65% | 1.32% |
| 30 Jun, 19 | 79.18% | 1.19% |
| 31 Mar, 19 | 81.43% | 1.08% |
| 31 Dec, 18 | 86.66% | 1.08% |
| 30 Sep, 18 | 89.77% | 1.09% |
| 30 Jun, 18 | 90.95% | 1.25% |
| 31 Mar, 18 | 85.18% | 0.97% |
| 31 Dec, 17 | 93.92% | 5.02% |
| 30 Sep, 17 | 43.24% | 2.43% |
| 30 Jun, 17 | 42.20% | 2.29% |
| 31 Mar, 17 | 42.89% | 2.29% |
| 31 Dec, 16 | 43.29% | 2.46% |
| 30 Sep, 16 | 41.92% | 2.38% |
| 30 Jun, 16 | 42.01% | 2.63% |
| 31 Mar, 16 | 39.94% | 2.32% |
| 31 Dec, 15 | 41.49% | - |
| 30 Jun, 10 | 0.01% | - |
As of 30 Jun 24, Voyager Therapeutics is held by 64.91% institutional shareholders, representing a 1.01% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 66 | -26.67% |
| 31 Mar, 24 | 90 | 76.47% |
| 31 Dec, 23 | 51 | -8.93% |
| 30 Sep, 23 | 56 | -27.27% |
| 30 Jun, 23 | 77 | 40.00% |
| 31 Mar, 23 | 55 | 66.67% |
| 31 Dec, 22 | 33 | 17.86% |
| 30 Sep, 22 | 28 | -22.22% |
| 30 Jun, 22 | 36 | -5.26% |
| 31 Mar, 22 | 38 | 58.33% |
| 31 Dec, 21 | 24 | - |
| 30 Sep, 21 | 24 | -25.00% |
| 30 Jun, 21 | 32 | -33.33% |
| 31 Mar, 21 | 48 | 17.07% |
| 31 Dec, 20 | 41 | 10.81% |
| 30 Sep, 20 | 37 | -22.92% |
| 30 Jun, 20 | 48 | -15.79% |
| 31 Mar, 20 | 57 | -19.72% |
| 31 Dec, 19 | 71 | -8.97% |
| 30 Sep, 19 | 78 | -1.27% |
| 30 Jun, 19 | 79 | 33.90% |
| 31 Mar, 19 | 59 | 13.46% |
| 31 Dec, 18 | 52 | -8.77% |
| 30 Sep, 18 | 57 | -26.92% |
| 30 Jun, 18 | 78 | 30.00% |
| 31 Mar, 18 | 60 | -22.08% |
| 31 Dec, 17 | 77 | 37.50% |
| 30 Sep, 17 | 56 | 51.35% |
| 30 Jun, 17 | 37 | 68.18% |
| 31 Mar, 17 | 22 | -31.25% |
| 31 Dec, 16 | 32 | 10.34% |
| 30 Sep, 16 | 29 | -23.68% |
| 30 Jun, 16 | 38 | 72.73% |
| 31 Mar, 16 | 22 | -37.14% |
| 31 Dec, 15 | 35 | - |
| 30 Jun, 10 | 1 | - |
66 institutional shareholders have increased their position in VYGR stock as of 30 Jun 24 compared to 90 in the previous quarter (a -26.67% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 39 | 39.29% |
| 31 Mar, 24 | 28 | -12.50% |
| 31 Dec, 23 | 32 | -3.03% |
| 30 Sep, 23 | 33 | 65.00% |
| 30 Jun, 23 | 20 | 42.86% |
| 31 Mar, 23 | 14 | -12.50% |
| 31 Dec, 22 | 16 | -20.00% |
| 30 Sep, 22 | 20 | -23.08% |
| 30 Jun, 22 | 26 | 52.94% |
| 31 Mar, 22 | 17 | -19.05% |
| 31 Dec, 21 | 21 | -32.26% |
| 30 Sep, 21 | 31 | 6.90% |
| 30 Jun, 21 | 29 | -3.33% |
| 31 Mar, 21 | 30 | -9.09% |
| 31 Dec, 20 | 33 | -19.51% |
| 30 Sep, 20 | 41 | 5.13% |
| 30 Jun, 20 | 39 | 8.33% |
| 31 Mar, 20 | 36 | -12.20% |
| 31 Dec, 19 | 41 | 51.85% |
| 30 Sep, 19 | 27 | -3.57% |
| 30 Jun, 19 | 28 | -17.65% |
| 31 Mar, 19 | 34 | - |
| 31 Dec, 18 | 34 | -5.56% |
| 30 Sep, 18 | 36 | 24.14% |
| 30 Jun, 18 | 29 | -3.33% |
| 31 Mar, 18 | 30 | 100.00% |
| 31 Dec, 17 | 15 | 25.00% |
| 30 Sep, 17 | 12 | 50.00% |
| 30 Jun, 17 | 8 | -60.00% |
| 31 Mar, 17 | 20 | 53.85% |
| 31 Dec, 16 | 13 | 30.00% |
| 30 Sep, 16 | 10 | 42.86% |
| 30 Jun, 16 | 7 | -46.15% |
| 31 Mar, 16 | 13 | - |
| 31 Dec, 15 | - | - |
| 30 Jun, 10 | - | - |
39 institutional shareholders have reduced their position in VYGR stock as of 30 Jun 24 compared to 28 in the previous quarter (a 39.29% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 129 | -4.44% | 37,074,437 | 7.46% | 64.91% | 1.01% | 66 | -26.67% | 39 | 39.29% |
| 31 Mar, 24 | 135 | 22.73% | 34,500,823 | 33.24% | 80.20% | 2.30% | 90 | 76.47% | 28 | -12.50% |
| 31 Dec, 23 | 110 | -3.51% | 25,893,556 | -1.14% | 59.03% | 1.63% | 51 | -8.93% | 32 | -3.03% |
| 30 Sep, 23 | 114 | 4.59% | 26,192,943 | 1.46% | 60.19% | 1.49% | 56 | -27.27% | 33 | 65.00% |
| 30 Jun, 23 | 109 | 25.29% | 25,817,269 | 13.55% | 63.54% | 2.03% | 77 | 40.00% | 20 | 42.86% |
| 31 Mar, 23 | 87 | 22.54% | 22,736,451 | -0.43% | 55.96% | 1.59% | 55 | 66.67% | 14 | -12.50% |
| 31 Dec, 22 | 71 | - | 22,833,566 | -0.61% | 59.23% | 1.66% | 33 | 17.86% | 16 | -20.00% |
| 30 Sep, 22 | 71 | -8.97% | 22,973,885 | 0.26% | 59.66% | 1.67% | 28 | -22.22% | 20 | -23.08% |
| 30 Jun, 22 | 78 | 2.63% | 22,914,615 | 7.86% | 59.83% | 1.92% | 36 | -5.26% | 26 | 52.94% |
| 31 Mar, 22 | 76 | 28.81% | 21,245,536 | 20.80% | 55.84% | 2.56% | 38 | 58.33% | 17 | -19.05% |
| 31 Dec, 21 | 59 | -11.94% | 17,587,798 | -17.53% | 46.69% | 1.47% | 24 | - | 21 | -32.26% |
| 30 Sep, 21 | 67 | -11.84% | 21,327,489 | -6.05% | 56.45% | 1.55% | 24 | -25.00% | 31 | 6.90% |
| 30 Jun, 21 | 76 | -21.65% | 22,700,706 | -13.57% | 60.40% | 1.23% | 32 | -33.33% | 29 | -3.33% |
| 31 Mar, 21 | 97 | -2.02% | 26,265,616 | -3.80% | 70.04% | 1.30% | 48 | 17.07% | 30 | -9.09% |
| 31 Dec, 20 | 99 | -8.33% | 27,303,735 | -1.53% | 73.53% | 1.33% | 41 | 10.81% | 33 | -19.51% |
| 30 Sep, 20 | 108 | -3.57% | 27,727,636 | -5.99% | 74.45% | 1.17% | 37 | -22.92% | 41 | 5.13% |
| 30 Jun, 20 | 112 | -4.27% | 29,492,954 | -1.49% | 79.65% | 1.21% | 48 | -15.79% | 39 | 8.33% |
| 31 Mar, 20 | 117 | -15.83% | 29,940,323 | -1.94% | 81.00% | 1.12% | 57 | -19.72% | 36 | -12.20% |
| 31 Dec, 19 | 139 | 5.30% | 30,533,156 | 0.54% | 85.05% | 1.25% | 71 | -8.97% | 41 | 51.85% |
| 30 Sep, 19 | 132 | 2.33% | 30,368,136 | 4.76% | 82.65% | 1.32% | 78 | -1.27% | 27 | -3.57% |
| 30 Jun, 19 | 129 | 15.18% | 28,989,591 | 6.74% | 79.18% | 1.19% | 79 | 33.90% | 28 | -17.65% |
| 31 Mar, 19 | 112 | -1.75% | 27,159,951 | -2.26% | 81.43% | 1.08% | 59 | 13.46% | 34 | - |
| 31 Dec, 18 | 114 | -6.56% | 27,786,932 | -3.84% | 86.66% | 1.08% | 52 | -8.77% | 34 | -5.56% |
| 30 Sep, 18 | 122 | -3.94% | 28,897,987 | -0.64% | 89.77% | 1.09% | 57 | -26.92% | 36 | 24.14% |
| 30 Jun, 18 | 127 | 14.41% | 29,083,589 | 7.51% | 90.95% | 1.25% | 78 | 30.00% | 29 | -3.33% |
| 31 Mar, 18 | 111 | 9.90% | 27,053,018 | 7.47% | 85.18% | 0.97% | 60 | -22.08% | 30 | 100.00% |
| 31 Dec, 17 | 101 | 32.89% | 25,173,586 | 122.51% | 93.92% | 5.02% | 77 | 37.50% | 15 | 25.00% |
| 30 Sep, 17 | 76 | 46.15% | 11,313,482 | 3.33% | 43.24% | 2.43% | 56 | 51.35% | 12 | 50.00% |
| 30 Jun, 17 | 52 | 13.04% | 10,949,069 | -1.01% | 42.20% | 2.29% | 37 | 68.18% | 8 | -60.00% |
| 31 Mar, 17 | 46 | -16.36% | 11,060,819 | 0.98% | 42.89% | 2.29% | 22 | -31.25% | 20 | 53.85% |
| 31 Dec, 16 | 55 | 10.00% | 10,954,007 | 2.97% | 43.29% | 2.46% | 32 | 10.34% | 13 | 30.00% |
| 30 Sep, 16 | 50 | 2.04% | 10,637,832 | 0.37% | 41.92% | 2.38% | 29 | -23.68% | 10 | 42.86% |
| 30 Jun, 16 | 49 | 13.95% | 10,598,354 | 5.81% | 42.01% | 2.63% | 38 | 72.73% | 7 | -46.15% |
| 31 Mar, 16 | 43 | 22.86% | 10,016,303 | -3.72% | 39.94% | 2.32% | 22 | -37.14% | 13 | - |
| 31 Dec, 15 | 35 | - | 10,403,219 | - | 41.49% | - | 35 | - | - | - |
| 30 Jun, 10 | 1 | - | 1,500 | - | 0.01% | - | 1 | - | - | - |
Voyager Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Voyager Therapeutics's stock was made by Swartz Robin on Apr 03 2024, selling 1,357 shares at $9.88 per share (valued at $13.41K).
Voyager Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | - | - |
| Q2 2024 | 10 | 2 | 500.00% |
| Q1 2024 | 11 | 7 | 157.14% |
| Q4 2023 | 1 | 1 | 100.00% |
| Q3 2023 | 2 | 3 | 66.67% |
| Q2 2023 | 11 | 4 | 275.00% |
| Q1 2023 | 11 | 25 | 44.00% |
| Q4 2022 | 2 | - | - |
| Q3 2022 | 2 | 5 | 40.00% |
| Q2 2022 | 10 | 2 | 500.00% |
| Q1 2022 | 13 | 12 | 108.33% |
| Q4 2021 | 3 | 7 | 42.86% |
| Q2 2021 | 9 | 1 | 900.00% |
| Q1 2021 | 12 | 6 | 200.00% |
| Q3 2020 | 1 | - | - |
| Q2 2020 | 7 | 2 | 350.00% |
| Q1 2020 | 8 | 3 | 266.67% |
| Q2 2019 | 12 | - | - |
| Q1 2019 | 9 | - | - |
| Q4 2018 | 1 | - | - |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Voyager Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | 2 | - |
| Q1 2024 | - | 7 | - |
| Q4 2023 | - | 1 | - |
| Q3 2023 | - | 2 | - |
| Q2 2023 | - | 3 | - |
| Q1 2023 | 1 | 23 | 4.35% |
| Q4 2022 | - | - | - |
| Q3 2022 | - | 5 | - |
| Q2 2022 | 2 | 2 | 100.00% |
| Q1 2022 | - | 9 | - |
| Q4 2021 | - | - | - |
| Q2 2021 | - | 2 | - |
| Q1 2021 | - | 6 | - |
| Q3 2020 | - | - | - |
| Q2 2020 | - | 2 | - |
| Q1 2020 | - | 3 | - |
| Q2 2019 | - | - | - |
| Q1 2019 | 1 | - | - |
| Q4 2018 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Voyager Therapeutics's stocks.
Voyager Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ARWR | Arrowhead Pharmaceuticals, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| MREO | Mereo BioPharma Group plc |
| DAWN | Day One Biopharmaceuticals, Inc. |
| PDSB | PDS Biotechnology Corporation |
| HOOK | HOOKIPA Pharma Inc. |
| PRQR | ProQR Therapeutics N.V. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ANNX | Annexon, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| LPTX | Leap Therapeutics, Inc. |
VYGR Ownership FAQ
Who Owns Voyager Therapeutics?
Voyager Therapeutics is owned by institutional shareholders (64.91%), insiders (16.86%), and public (18.23%). The largest institutional shareholder of Voyager Therapeutics is BLACKROCK INC. (9.30% of total shares) and the top mutual fund owner is Tema ETF Trust (0.34% of total shares).
Who are the major institutional shareholders of Voyager Therapeutics?
Voyager Therapeutics's major institutional shareholders are BLACKROCK INC., ARMISTICE CAPITAL, LLC, ECOR1 CAPITAL, LLC, VANGUARD GROUP INC, and FARALLON CAPITAL MANAGEMENT LLC. The top five shareholders own together 34.60% of the company's share outstanding.
How many Voyager Therapeutics shareholders are there?
As of Jun 2024, there are 129 institutional shareholders of Voyager Therapeutics.
What percentage of Voyager Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC owns 5.31M shares of Voyager Therapeutics, representing 9.30% of the company's total shares outstanding, valued at $42.02M (as of Jun 2024).
What percentage of Voyager Therapeutics is owned by ARMISTICE CAPITAL, LLC?
As of Jun 2024, ARMISTICE CAPITAL, LLC holds 5.2M shares of Voyager Therapeutics (VYGR), compromising 9.10% of the company, valued at $41.13M.
What percentage of Voyager Therapeutics is owned by ECOR1 CAPITAL, LLC?
ECOR1 CAPITAL, LLC is the third largest holder of Voyager Therapeutics. The company owns 3.92M of the company's shares outstanding (worth $30.99M).